These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24369732)

  • 1. Expression and prognostic significance of CIP2A in cutaneous malignant melanoma.
    Shi F; Ding Y; Ju S; Wu X; Cao S
    Biomarkers; 2014 Feb; 19(1):70-6. PubMed ID: 24369732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.
    Ren J; Li W; Yan L; Jiao W; Tian S; Li D; Tang Y; Gu G; Liu H; Xu Z
    Br J Cancer; 2011 Dec; 105(12):1905-11. PubMed ID: 22075943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma.
    Flørenes VA; Emilsen E; Dong HP; Førsund M; Holm R; Slipicevic A
    Cancer Med; 2015 Jun; 4(6):903-13. PubMed ID: 25663244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells.
    Chen XD; Tang SX; Zhang JH; Zhang LT; Wang YW
    Oncol Rep; 2017 Aug; 38(2):1005-1012. PubMed ID: 28656258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
    Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
    Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIP2A is a predictor of poor prognosis in colon cancer.
    Teng HW; Yang SH; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Chen PC; Lan YT; Lin CC; Hsu YN; Wang HW; Chen KF
    J Gastrointest Surg; 2012 May; 16(5):1037-47. PubMed ID: 22328001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CIP2A in clear cell renal cell carcinoma promotes cellular epithelial-mesenchymal transition and is associated with poor prognosis.
    Tang Q; Wang Q; Zeng G; Li Q; Jiang T; Zhang Z; Zheng W; Wang K
    Oncol Rep; 2015 Nov; 34(5):2515-22. PubMed ID: 26327467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
    Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH
    Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIP2A is overexpressed in human endometrioid adenocarcinoma and regulates cell proliferation, invasion and apoptosis.
    Yu N; Zhang T; Zhao D; Cao Z; Du J; Zhang Q
    Pathol Res Pract; 2018 Feb; 214(2):233-239. PubMed ID: 29274810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.
    Chen KF; Liu CY; Lin YC; Yu HC; Liu TH; Hou DR; Chen PJ; Cheng AL
    Oncogene; 2010 Nov; 29(47):6257-66. PubMed ID: 20729919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer.
    Birkman EM; Elzagheid A; Jokilehto T; Avoranta T; Korkeila E; Kulmala J; Syrjänen K; Westermarck J; Sundström J
    Cancer Med; 2018 Mar; 7(3):698-706. PubMed ID: 29441695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of CIP2A in Esophagogastric Junction Adenocarcinoma: A Study of 65 Patients and a Meta-Analysis.
    Li Y; Wang M; Zhu X; Cao X; Wu Y; Fang F
    Dis Markers; 2019; 2019():2312439. PubMed ID: 31534561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth.
    Khanna A; Thoms JAI; Stringer BW; Chung SA; Ensbey KS; Jue TR; Jahan Z; Subramanian S; Anande G; Shen H; Unnikrishnan A; McDonald KL; Day BW; Pimanda JE
    Mol Cancer Res; 2020 May; 18(5):709-722. PubMed ID: 32079743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of CIP2A in cholangiocarcinoma and correlation with poor prognosis.
    Xu P; Huang Q; Xie F; Xu XL; Shao F
    Hepatogastroenterology; 2013 Jun; 60(124):669-72. PubMed ID: 24046827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of sCIP2A levels in breast cancer.
    Xing ML; Lu YF; Wang DF; Zou XY; Zhang SX; Yun Z
    Eur Rev Med Pharmacol Sci; 2016; 20(1):82-91. PubMed ID: 26813457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells.
    Pallai R; Bhaskar A; Sodi V; Rice LM
    Transcription; 2012; 3(6):323-35. PubMed ID: 23117818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
    Guo Z; Liu D; Su Z
    Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
    He H; Wu G; Li W; Cao Y; Liu Y
    Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma.
    Wei Y; Du Y; Chen X; Li P; Wang Y; Zang W; Zhao L; Li Z; Zhao G
    Tumour Biol; 2014 Aug; 35(8):8007-15. PubMed ID: 24839010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated ankyrin repeat-rich membrane spanning protein contributes to tumour progression in cutaneous melanoma.
    Liao YH; Hsu SM; Yang HL; Tsai MS; Huang PH
    Br J Cancer; 2011 Mar; 104(6):982-8. PubMed ID: 21343931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.